These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) and Chimerix (Nasdaq: CMRX) (“Chimerix”), today announced the companies have entered into a definitive agreement for Jazz to acquire ...

The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine.

New types of wearables and devices can record bodily data or simulate the senses without needing to meet stringent med-tech ...